121 related articles for article (PubMed ID: 32710971)
1. The indirubin derivative 6-bromoindirubin-3'-glycerol-oxime ether (6BIGOE) potently modulates inflammatory cytokine and prostaglandin release from human monocytes through GSK-3 interference.
Czapka A; König S; Pergola C; Grune C; Vougogiannopoulou K; Skaltsounis AL; Fischer D; Werz O
Biochem Pharmacol; 2020 Oct; 180():114170. PubMed ID: 32710971
[TBL] [Abstract][Full Text] [Related]
2. Drug delivery of 6-bromoindirubin-3'-glycerol-oxime ether employing poly(D,L-lactide-co-glycolide)-based nanoencapsulation techniques with sustainable solvents.
Czapka A; Grune C; Schädel P; Bachmann V; Scheuer K; Dirauf M; Weber C; Skaltsounis AL; Jandt KD; Schubert US; Fischer D; Werz O
J Nanobiotechnology; 2022 Jan; 20(1):5. PubMed ID: 34983538
[TBL] [Abstract][Full Text] [Related]
3. Modulation of glioma-inflammation crosstalk profiles in human glioblastoma cells by indirubin-3'-(2,3 dihydroxypropyl)-oximether (E804) and 7-bromoindirubin-3'-oxime (7BIO).
Scobie MR; Houke HR; Rice CD
Chem Biol Interact; 2019 Oct; 312():108816. PubMed ID: 31505164
[TBL] [Abstract][Full Text] [Related]
4. The Indirubin Derivative 6-Bromoindirubin-3'-Oxime Activates Proteostatic Modules, Reprograms Cellular Bioenergetic Pathways, and Exerts Antiaging Effects.
Tsakiri EN; Gaboriaud-Kolar N; Iliaki KK; Tchoumtchoua J; Papanagnou ED; Chatzigeorgiou S; Tallas KD; Mikros E; Halabalaki M; Skaltsounis AL; Trougakos IP
Antioxid Redox Signal; 2017 Nov; 27(14):1027-1047. PubMed ID: 28253732
[TBL] [Abstract][Full Text] [Related]
5. 6-bromo-indirubin-3'-oxime (6BIO), a Glycogen synthase kinase-3β inhibitor, activates cytoprotective cellular modules and suppresses cellular senescence-mediated biomolecular damage in human fibroblasts.
Sklirou AD; Gaboriaud-Kolar N; Papassideri I; Skaltsounis AL; Trougakos IP
Sci Rep; 2017 Sep; 7(1):11713. PubMed ID: 28916781
[TBL] [Abstract][Full Text] [Related]
6. 7-Bromoindirubin-3'-oxime induces caspase-independent cell death.
Ribas J; Bettayeb K; Ferandin Y; Knockaert M; Garrofé-Ochoa X; Totzke F; Schächtele C; Mester J; Polychronopoulos P; Magiatis P; Skaltsounis AL; Boix J; Meijer L
Oncogene; 2006 Oct; 25(47):6304-18. PubMed ID: 16702956
[TBL] [Abstract][Full Text] [Related]
7. An inhibitor-driven study for enhancing the selectivity of indirubin derivatives towards leishmanial Glycogen Synthase Kinase-3 over leishmanial cdc2-related protein kinase 3.
Efstathiou A; Gaboriaud-Kolar N; Smirlis D; Myrianthopoulos V; Vougogiannopoulou K; Alexandratos A; Kritsanida M; Mikros E; Soteriadou K; Skaltsounis AL
Parasit Vectors; 2014 May; 7():234. PubMed ID: 24886176
[TBL] [Abstract][Full Text] [Related]
8. 6-Br-5methylindirubin-3'oxime (5-Me-6-BIO) targeting the leishmanial glycogen synthase kinase-3 (GSK-3) short form affects cell-cycle progression and induces apoptosis-like death: exploitation of GSK-3 for treating leishmaniasis.
Xingi E; Smirlis D; Myrianthopoulos V; Magiatis P; Grant KM; Meijer L; Mikros E; Skaltsounis AL; Soteriadou K
Int J Parasitol; 2009 Oct; 39(12):1289-303. PubMed ID: 19445946
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of GSK-3 reduces prostaglandin E2 production by decreasing the expression levels of COX-2 and mPGES-1 in monocyte/macrophage lineage cells.
Noma T; Takahashi-Yanaga F; Arioka M; Mori Y; Sasaguri T
Biochem Pharmacol; 2016 Sep; 116():120-9. PubMed ID: 27453433
[TBL] [Abstract][Full Text] [Related]
10. 6BIO Enhances Oligonucleotide Activity in Cells: A Potential Combinatorial Anti-androgen Receptor Therapy in Prostate Cancer Cells.
Zhang X; Castanotto D; Nam S; Horne D; Stein C
Mol Ther; 2017 Jan; 25(1):79-91. PubMed ID: 28129131
[TBL] [Abstract][Full Text] [Related]
11. Indirubin-3'-oxime prevents hepatic I/R damage by inhibiting GSK-3beta and mitochondrial permeability transition.
Varela AT; Simões AM; Teodoro JS; Duarte FV; Gomes AP; Palmeira CM; Rolo AP
Mitochondrion; 2010 Aug; 10(5):456-63. PubMed ID: 20433952
[TBL] [Abstract][Full Text] [Related]
12. Indirubin core structure of glycogen synthase kinase-3 inhibitors as novel chemotype for intervention with 5-lipoxygenase.
Pergola C; Gaboriaud-Kolar N; Jestädt N; König S; Kritsanida M; Schaible AM; Li H; Garscha U; Weinigel C; Barz D; Albring KF; Huber O; Skaltsounis AL; Werz O
J Med Chem; 2014 May; 57(9):3715-23. PubMed ID: 24697244
[TBL] [Abstract][Full Text] [Related]
13. Indirubin derivative 6BIO suppresses metastasis.
Braig S; Kressirer CA; Liebl J; Bischoff F; Zahler S; Meijer L; Vollmar AM
Cancer Res; 2013 Oct; 73(19):6004-12. PubMed ID: 23946383
[TBL] [Abstract][Full Text] [Related]
14. S632A3, a new glutarimide antibiotic, suppresses lipopolysaccharide-induced pro-inflammatory responses via inhibiting the activation of glycogen synthase kinase 3β.
Deng H; Zhang N; Wang Y; Chen J; Shen J; Wang Z; Xu R; Zhang J; Song D; Li D
Exp Cell Res; 2012 Dec; 318(20):2592-603. PubMed ID: 22975730
[TBL] [Abstract][Full Text] [Related]
15. Proliferative and androgenic effects of indirubin derivatives in LNCaP human prostate cancer cells at sub-apoptotic concentrations.
Rivest P; Renaud M; Sanderson JT
Chem Biol Interact; 2011 Feb; 189(3):177-85. PubMed ID: 21111724
[TBL] [Abstract][Full Text] [Related]
16. Indirubin-3'-oxime inhibits inflammatory activation of rat brain microglia.
Jung HJ; Nam KN; Son MS; Kang H; Hong JW; Kim JW; Lee EH
Neurosci Lett; 2011 Jan; 487(2):139-43. PubMed ID: 20946938
[TBL] [Abstract][Full Text] [Related]
17. Indirubin-3'-monoxime, a derivative of a Chinese anti-leukemia medicine, inhibits Notch1 signaling.
Lee MJ; Kim MY; Mo JS; Ann EJ; Seo MS; Hong JA; Kim YC; Park HS
Cancer Lett; 2008 Jul; 265(2):215-25. PubMed ID: 18343569
[TBL] [Abstract][Full Text] [Related]
18. Indirubin-3-Oxime Effectively Prevents 6OHDA-Induced Neurotoxicity in PC12 Cells via Activating MEF2D Through the Inhibition of GSK3β.
Hu S; Cui W; Zhang Z; Mak S; Xu D; Li G; Hu Y; Wang Y; Lee M; Tsim KW; Han Y
J Mol Neurosci; 2015 Dec; 57(4):561-70. PubMed ID: 26346600
[TBL] [Abstract][Full Text] [Related]
19. Glycogen synthase kinase 3 involvement in the excessive proinflammatory response to LPS in patients with decompensated cirrhosis.
Coant N; Simon-Rudler M; Gustot T; Fasseu M; Gandoura S; Ragot K; Abdel-Razek W; Thabut D; Lettéron P; Ogier-Denis E; Ouziel R; Devière J; Lizard G; Tellier Z; Lebrec D; Moreau R
J Hepatol; 2011 Oct; 55(4):784-93. PubMed ID: 21334395
[TBL] [Abstract][Full Text] [Related]
20. Indirubin-3'-(2,3 dihydroxypropyl)-oximether (E804) is a potent modulator of LPS-stimulated macrophage functions.
Babcock AS; Anderson AL; Rice CD
Toxicol Appl Pharmacol; 2013 Jan; 266(1):157-66. PubMed ID: 23107598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
